BIIB · Healthcare
Biogen Inc
24/100
Smart-money confidence1 of 3 sources positive
Bearish — money moving out
No standout activity across the feeds we track.
Hedge funds
32
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$31.0B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NasdaqGS
About BIOGEN INC
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psoriasis; BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; FLIXABI, an infliximab biosimilar referencing REMICADE. It offers LEQEMBI for the…
Who's behind the signal
Every informed buyer we can see on BIIB, across all three feeds.
Hedge funds · 6
Gotham Asset Mgmt (Greenblatt)
Increased +8%
AQR Capital Management
Increased +26%
Citadel Advisors
Increased +242%
Glenview Capital Mgmt (Robbins)
Decreased −80%
Point72 (Steve Cohen)
Decreased −71%
Millennium Management (Englander)
Decreased −92%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 30 on record
Disclosures from 2014-03-27 to 2022-03-17
The newest disclosure we hold for this stock is 2022-03-17.
That is the end of our data, not necessarily the end of the trading — our
bulk STOCK Act archive stops there and newer filings arrive through a
separate live feed. Treat the absence of recent rows as “not covered”,
not as “no trades”.
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2022-03-17 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2022-01-14 | Kathy E. Manning · D-NC | House | Sold | $1,001 - $15,000 |
| 2022-01-10 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2021-12-09 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2021-10-18 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2021-09-15 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2021-06-08 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2021-02-16 | Peter Meijer · R-MI | House | Sold | $15,001 - $50,000 |
| 2021-01-04 | Chris Jacobs · R-NY | House | Sold | $1,001 - $15,000 |
| 2020-12-22 | Gilbert Ray Cisneros, Jr. · D-CA | House | Sold | $1,001 - $15,000 |
Show the other 20
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2020-09-16 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-07-07 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
| 2020-04-29 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2020-03-18 | Gilbert Ray Cisneros, Jr. · D-CA | House | Sold | $1,001 - $15,000 |
| 2020-02-07 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $1,001 - $15,000 |
| 2019-06-24 | Donna E. Shalala · D-FL | House | Sold | $1,001 - $15,000 |
| 2019-03-22 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2018-01-08 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2016-12-23 | Sheldon Whitehouse · D-RI | Senate | Sold | $1,001 - $15,000 |
| 2016-12-13 | Sheldon Whitehouse · D-RI | Senate | Sold | $15,001 - $50,000 |
| 2016-07-21 | James M. Inhofe · R-OK | Senate | Sold | $50,001 - $100,000 |
| 2015-08-28 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2015-08-10 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2015-08-04 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2015-07-10 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2015-07-09 | James M. Inhofe · R-OK | Senate | Bought | $15,001 - $50,000 |
| 2015-05-07 | Sheldon Whitehouse · D-RI | Senate | Bought | $15,001 - $50,000 |
| 2015-04-07 | Sheldon Whitehouse · D-RI | Senate | Bought | $1,001 - $15,000 |
| 2014-07-23 | Susan M. Collins · R-ME | Senate | Sold | $1,001 - $15,000 |
| 2014-03-27 | Susan M. Collins · R-ME | Senate | Sold | $1,001 - $15,000 |
Not a model pick — but on our radar.
BIOGEN INC isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
0
New positions
3
Increasing
3
Decreasing
0
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
% of portfolio
0.2%
Position change
+8%
0.2% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
+26%
0.2% of AQR Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
+242%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.2×
% of portfolio
0.3%
Position change
−80%
0.3% of Glenview Capital Mgmt's portfolio
Trust weight: 1.1×
% of portfolio
0.3%
Position change
−71%
0.3% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−92%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to BIOGEN INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell BIOGEN INC or any security.
订阅每周更新
我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订